
Daily Derm Times: April 11, 2025
Key Takeaways
- Menopausal acne treatment should consider hormonal shifts, skin sensitivity, and emotional well-being for effective management.
- Codex Labs' lotion is the first eczema OTC topical certified as microbiome-friendly and accepted by the NEA.
Catch up on dermatology news, highlights, and insights from the past 24 hours.
To stay up-to-date with the latest dermatology news, sign up to receive our
How to Best Support Women With Menopausal Acne
Menopausal acne is rising yet underexplored; treatment must address hormonal shifts, skin sensitivity, and patient emotional well-being.
Codex Labs Lotion is First Eczema OTC Topical to Achieve Microbiome-Friendly Certification
The company also announced in a press release that the product received the Seal of Acceptance by the NEA.
Subcutaneous Methotrexate Shows Promise Over Oral Route in Plaque Psoriasis Treatment
Subcutaneous methotrexate may offer improved efficacy and patient adherence in psoriasis treatment, though it comes at a higher cost.
Exploring Off-Label Uses of Topical JAK Inhibitors
While approved for vitiligo and atopic dermatitis, ruxolitinib cream may help treat other inflammatory skin diseases.
New Qtorin Rapamycin Data Featured at World Congress of Pediatric Dermatology
The presentation, led by Amy Paller, MS, MD, highlighted the upcoming phase 3 SELVA study for microcystic lymphatic malformations.
Acupuncture Reduces Frown Lines in Clinical Trial
Satisfaction levels remained high at 12 weeks post-treatment among those who received acupuncture.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.


















